Collectively, these findings indicate that NTZ, particularly at the 400 mg/kg dose, effectively modulates several key inflammatory cyto-kines, including IL-6, TNF-α, NF-κB, and STAT-3, positioning it as a promising candidate for targeting immune responses in rheumatoid arthritis, as shown in Figure 2. This evidence concerns the gene IL6 and rheumatoid arthritis.